Probiotics, Antibiotics and the Post-Antibiotic Microbiota
Starting soon · Not applicable · Has a placebo group
Conditions studied: Probiotic, Microbiome
In brief
Antibiotic therapy can cause gastrointestinal dysbiosis and this study will assess the impact of probiotic supplementation on microbiological composition and functionality pre- and post- antibiotic therapy
Key facts
- Study ID
- NCT07425704
- Run by
- Cultech Ltd
- People needed
- 50
- Starts
- 2026-04-13
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-03-18
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults, aged 18-40.
- Been prescribed an oral dose of cephalosporin antibiotic lasting 5 - 10 days.
- Willing to provide stool samples and, for women, vaginal samples.
- Willing to avoid consumption of any other probiotic capsules/tablets during the study.
You may not qualify if…
- If antibiotics prescribed are intended to treat any gastrointestinal or vaginally related issue.
- Any antibiotic intake within the last 3 months.
- Immunodeficient or undergoing immunosuppressive therapy.
- Currently diagnosed with diabetes/cardiovascular disease/cancer/dementia.
- Any unexplained loss of weight in recent months.
- Known to be pregnant or <3 months postpartum.
Where it is running
- Comac Medical — Sofia, Bulgaria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.